Clinical trial
Lyme Disease Prevention Program
NCT00000432 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00000432 |
|---|---|
| Title | Lyme Disease Prevention Program |
| Official title | A Controlled Trial of a Primary and Secondary Program for Lyme Disease |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lyme Disease, Tick-Borne Diseases |
| Intervention type | Behavioral |
| Interventions | Education about disease prevention |
| Enrollment | 20,000 |
| Start date | Apr 1, 1997 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2001 |
| First posted | Jan 19, 2000 |
| Last update posted | Dec 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: